A study between Magnesium sulphate and Fentanyl as additive to 0.125% Ropivacaine in Labor Epidural analgesia

Comparative study between MgSO4 5mg/ml and fentanyl 2 mics/ml as adjuvant to 0.125% ropivacaine for evaluating the efficacy in labor epidural analgesia.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049893

Enrollment

Registered

2023-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: Comparison of Magnesium sulphate and Fentanyl as additives to ropivacaine: Magnesium sulphate of dose 5mg/ml is administered as an additive to 0.125% Ropivacaine through epidura

Eligibility

Inclusion criteria

Inclusion criteria: Patient request;Primigravida;Aged >18years;ASA II;BMI <30Kg/m2

Exclusion criteria

Exclusion criteria: Patient refusal;ASA III & IV;History of coagulation disorder;Inflammatory/Infective skin lesions at the site;Any co-morbidity;BMI >30 kg/m2

Design outcomes

Primary

Measure	Time frame
Onset of sensory block Duration of Analgesia VAS ScoreTimepoint: Basal,5 min,10min,15 min,30 min,60 min,120 min,180 min,240 min	—

Secondary

Measure	Time frame
side effects if anyTimepoint: Basal,5 min,10 min,15 min,30 min,60 min,120 min,180 min,240 min,	—

Countries

India

Contacts

Public ContactPoojitha P

Narayana Medical College and Hospital

sindhuradwarak@gmail.com9108302760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026